GUARDS | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

GUARDS

GUARDS

GUARDS

Breadcrumb

  • Home
  • What We Do
  • GUARDS

DEA’s Newly Developed GUARDS Method

THE PROBLEM: Under current jurisdictional requirements, reporting of laboratory analysis findings varies throughout municipal, county, state, and federal laboratories. This disparity sometimes results in some laboratories not reporting lower-scheduled or non-controlled substances such as fentanyl or xylazine, when found in mixtures containing a higher scheduled drug, like heroin.

THE SOLUTION: The GUARDS method was developed and validated to address these and other US-wide reporting discrepancies by providing laboratories with a standardized GC-MS screening method that allows for consistent analysis and reporting of both commonly encountered drugs as well as emergent compounds.

With DEA (and other) laboratories using the GUARDS method, data could be assessed and compared nationwide allowing the early reporting of regionally detected NPS and the monitoring of trends.

DEA Seal - Color Logo

GUARDS Vision

Develop a standardized method to separate as many compounds as possible (including isomers) to share with the forensic seized-drug community and assist in standardized identification and reporting of compounds in seized drug samples.
Decorative icons regarding the GUARDS app

Why GUARDS?

The GUARDS method offers great selectivity for the vast majority of seized drugs routinely encountered by laboratories.

Mission First:

Our mission is to turn evidence into information. A streamlined and standardized collection of information means we can collect more information with fewer methods.
 

Collaboration:

Expand collaborative partnerships and lead the forensic community by providing a standardized analysis method for seized drugs and help standardize reporting. See Figure 1

Information Sharing:

Provide and get more information into the environment to contribute to the mission and assist the community.

Benefits:

Advanced analytical information – eliminates the need for multiple chromatographic methods by separating Fluoro- & Chloro-fentanyl positional isomers and derivatization of methamphetamine enantiomers. See Figure 2

Figure 1

Consistent results standardized method
Click to enlarge
Figure_4_Chromatogram

Figure 2

Separation of fentanyl positional isomers
Click to enlarge
Chromatogram 2

Development of the Guards Method

Involved over 90 iterations and three stationary phases while monitoring system suitability using multiple sets of forensically relevant, close-eluting compounds, including fentanyl analogues and positional isomers. 

The GUARDS method offers great selectivity for the vast majority of seized drugs routinely encountered by laboratories. Table 1 lists retention time (RT) values for the 15 most frequently identified compounds in the DEA lab system (OCT ‘23 – JUL ‘24) using the GUARDS method.

Primary DrugRT (min.)

Amphetamine

2.090

Methamphetamine

2.389

3,4-MDMA

4.566

N,N-Dimethylpentylone

5.958

Ketamine

6.176

Cocaine

7.971

Δ9 THC

9.036

Hydrocodone

9.772

Oxycodone

10.379

para-Fluorofentanyl

10.743

Heroin

10.993

Fentanyl

11.205

Alprazolam

13.176

Bromazolam

13.862

Protonitazene

14.617

Table 1. 15 compounds most frequently identified throughout DEA laboratories during the first three quarters of FY 2024

RT PRECISION:  Within-day: < 0.19% RSD
Intermediate (over 5 weeks): < 1.2% RSD (DMSO2)
Reproducibility (across labs): < 5% RSD 

Compound

Avg. RT (min.)

% RSD

Avg. RRT

% RSD

Dimethyl Sulfone

1.43

4.14

0.21

2.87

Cocaine

7.94

1.34

1.14

0.13

Fentanyl (0.5%)

11.14

1.59

1.61

0.31

Trazodone

14.92

1.01

1.88

0.38

Table 2: Summary of GUARDS chromatographic results collected during verification assessments for four representative compounds across 29 instruments and 10 laboratories.

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Who We Are
  • What We Do
  • Careers
  • Resources
Back
  • About
  • Mission
  • History
  • Divisions
  • DEA Museum
  • Wall of Honor
  • Contact Us
Back
  • Domestic Divisions
  • Foreign Divisions
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Forensic Sciences
  • Law Enforcement
  • Education and Prevention
  • Drug Information
  • News
  • Campaigns
Back
  • GUARDS
  • Forensic Sciences Policy
  • Forensic Science Organizations
  • Forensic Science Contact
Back
  • DEA Office of Training
  • El Paso Intelligence Center (EPIC)
  • Intelligence
  • Operations
Back
  • Office of Training Programs
Back
  • Administrative Law Judges
  • DEA Asset Forfeiture
  • Domestic Cannabis Suppression / Eradication Program
  • HIDTA
  • OCDETF
Back
  • Family Summit
  • Red Ribbon
  • Kiki and the History of Red Ribbon Week
  • Red Ribbon Toolkit - Resources For Your Community
  • DEA’s Family Summit
  • Operation Engage
  • Community Outreach
  • Just Think Twice
  • Campus Drug Prevention
  • Get Smart About Drugs
  • Operation Prevention
Back
  • Drug Policy
  • Drug Scheduling
  • The Controlled Substances Act
Back
  • Alerts
  • Press Releases
  • Most Wanted Fugitives
  • Stories
  • Events
  • Speeches
  • Testimony
Back
  • All Fugitives
Back
  • One Pill Can Kill
  • DEA National Prescription Drug Take Back Day
Back
  • Senior Citizens
  • Partner Toolbox
  • Social Media Campaign
Back
  • Special Agent
  • Diversion Investigator
  • Intelligence Research Specialist
  • Forensic Sciences Careers
  • Professional & Administrative Careers
  • Student & Entry Level Careers
  • Employment Eligibility
  • How to Apply
Back
  • Special Agent FAQs
Back
  • Diversion Investigator Job Announcement
Back
  • Intelligence Research Specialist Job Announcements
  • Intelligence Research Specialists FAQs
  • Schedule A Hiring Authority: Intelligence Research Specialist
Back
  • How To Claim Veterans' Preference
  • Priority Consideration
  • Benefits
  • Veterans and People With Disabilities
  • Operation Warfighter
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Data and Statistics
  • FOIA
  • Publications
  • Media Galleries
  • Victim Witness Assistance Program
Back
  • Domestic Arrests
  • Staffing and Budget
Back
  • About FOIA
  • Contact DEA FOIA
  • Make a Request
  • What Happens After Making a Request
  • Requester Categories
  • Fees Charged
  • Fee Waiver
  • FOIA FAQ
  • FOIA Logs and Reports
  • FOIA Library
  • Additional FOIA Links
  • FOIA Exemptions
  • What Are Exclusions?
  • Privacy Act
  • Privacy Act Exemptions
  • Privacy Impact Assessment and Management Information Systems
Back
  • Victim Witness Assistance Program Resources
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español